Teaneck, NJ — Kelly Heyboer reports in The Star-Ledger that President Donald J. Trump is considering a Fairleigh Dickinson University official, Dr. Joseph Gulfo, who wrote a book critical of the Food and Drug Administration (FDA), is one of President Donald Trump’s top choices to lead the federal agency.
Joseph Gulfo, M.D., executive director of Fairleigh Dickinson’s Lewis Center for Healthcare Innovation and Technology, is one of the names being vetted for the FDA commissioner job, according to the political website The Hill and several pharmaceutical industry publications.
Gulfo did not respond to requests to comment on the reports.
However, last week the Bergen County native used his Twitter page @josephgulfo to retweet stories about his name being floated for the job.
Joseph Gulfo, M.D., executive director of Fairleigh Dickinson’s Lewis Center for Healthcare Innovation and Technology, is one of the names being vetted for the FDA commissioner job, according to the political website The Hill and several pharmaceutical industry publications.
Gulfo did not respond to requests to comment on the reports.
However, last week the Bergen County native used his Twitter page @josephgulfo to retweet stories about his name being floated for the job.
Fairleigh Dickinson officials also posted links to a story about the possibility of Gulfo being named FDA commissioner on the school’s official social media accounts and website.
Dr. Gulfo, a former biotech executive and entrepreneur, has written frequently about how to reform the FDA, the Maryland-based federal agency that oversees food safety and the approval of drugs.
He is the author of The Care Quotient: Transforming Business Through People (September 2016) and Innovation Breakdown: How the FDA and Wall Street Cripple Medical Advances (June 2014).
On December 14, 2016, Dr. Gulfo wrote an article in The Hill that offered Mr. Trump advice on picking a new FDA chief.
“If he truly wants to reform the FDA to put greater focus on the need of patients for new and innovative medical products, his new commissioner absolutely must be a strong leader who can reverse the culture of fear and inertia that has hamstrung the delivery of innovative medical products to patients,” Gulfo wrote.
Dr. Gulfo, 53, grew up in Haworth and earned his medical degree from New Jersey Medical School at the former University of Medicine and Dentistry of New Jersey (now part of Rutgers University).
He also holds a master’s in business administration from Seton Hall University, according to his bio.
Dr. Gulfo, a former biotech executive and entrepreneur, has written frequently about how to reform the FDA, the Maryland-based federal agency that oversees food safety and the approval of drugs.
He is the author of The Care Quotient: Transforming Business Through People (September 2016) and Innovation Breakdown: How the FDA and Wall Street Cripple Medical Advances (June 2014).
On December 14, 2016, Dr. Gulfo wrote an article in The Hill that offered Mr. Trump advice on picking a new FDA chief.
“If he truly wants to reform the FDA to put greater focus on the need of patients for new and innovative medical products, his new commissioner absolutely must be a strong leader who can reverse the culture of fear and inertia that has hamstrung the delivery of innovative medical products to patients,” Gulfo wrote.
Dr. Gulfo, 53, grew up in Haworth and earned his medical degree from New Jersey Medical School at the former University of Medicine and Dentistry of New Jersey (now part of Rutgers University).
He also holds a master’s in business administration from Seton Hall University, according to his bio.
